There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...
Among them are CRISPR Therapeutics (NASDAQ: CRSP) and Merck (NYSE: MRK), two companies that develop innovative medical ...
21h
CervoMed's stock soars 400% on promising dementia drug data. See more on insights, potential concerns, and what it means for ...
FDA finds benzene contamination, Tronox to close a pigment plant, Sofinnova launches a European biotech fund, and more ...
During the recent period between index selection dates, U.S. stock markets faced a steep decline, with the S&P 500 falling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback